Delivery Order SPE2DR25D1202-SPE2DR26F73WV
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 26, 2025, by the Defense Logistics Agency for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order has a ceiling value of $3,750.79 and an ultimate completion date of November 28, 2025. The contract is not set-aside and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,258.92 by the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. Performance will be completed at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,349.17 by the Defense Logistics Agency on September 9, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is not set-aside and was competitively awarded with a firm fixed price structure and an ultimate completion date of September 10, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $7,351.22 by the Defense Logistics Agency on November 17, 2025, with an ultimate completion date of November 18, 2025. The contract covers the supply of Repatha 140 mg/ml SureClick auto-injector medication, with performance taking place at the company's Conshohocken facility. This delivery order was competitively awarded with no...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,922.90 firm fixed-price delivery order for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 6, 2025. This competitively awarded contract, issued on November 5, 2025, represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a $34,089.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. The contract, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order (4570029538) by the Defense Logistics Agency (DLA) on November 17, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, with a ceiling value of $28,706.24 under firm fixed pricing. The award is non-competitive and represents a child contract under the vendor's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $15,965.27 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on January 9, 2026, with completion targeted for January 12, 2026. This competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The contract carries no set-aside designation, reflecting full and open...
- The Defense Logistics Agency awarded a $12,072.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-competitive delivery order, which is set to be completed by November 18, 2025, represents a routine pharmaceutical procurement for the federal medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $1,196.22 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F73WVDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $61,117.01 by the Defense Logistics Agency on January 12, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The ultimate completion date is set for January 13, 2026. This delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally. The Defense Logistics Agency procures pharmaceutical products for military treatment facilities and the Defense Health Agency to support operational readiness and military personnel healthcare. Repatha is a biologic medication used for cholesterol management in eligible patients, consistent with the comprehensive range of prescription medications and specialty pharmaceuticals that AmerisourceBergen delivers through its federal contract portfolio. The firm fixed-price structure and rapid completion timeline reflect the efficiency required in military medical supply chains, where pharmaceutical availability directly impacts military medical operations and beneficiary care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.1k | 1/11/26 |